AlphaYouAC
Insider selling
Akos Czibere sold $1.4M of Aktis Oncology, Inc. (AKTS) stock
Akos Czibere, Chief Medical Officer of Aktis Oncology, Inc. (AKTS), sold 50,000 shares of AKTS stock worth $1.4M, per an SEC Form 4 filed Jul 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 8, 2026, 2 days before it was made public.
AKTS has moved -25.3% since the trade date, from $28.69 to $21.43 (Sep 21, 2026 close).
- Traded
- Jul 8, 2026
- Disclosed
- Jul 10, 2026
- Filing delay
- 2 days
- Price since
- -25.3%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More AKTS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.